Boston Scientific (BSX) Change in Acquisitions & Divestments (2009 - 2021)

Boston Scientific (BSX) reported Change in Acquisitions & Divestments of -$23.0 million for Q2 2021, down 160.53% sequentially from $38.0 million in Q1 2021.

Boston Scientific (BSX) Change in Acquisitions & Divestments (2009 - 2021) Analysis & Trends

Boston Scientific (BSX) has 4 years of Change in Acquisitions & Divestments data on file, last reported at -$23.0 million in Q2 2021.

  • For the quarter ending Q2 2021, Change in Acquisitions & Divestments changed N/A year-over-year to -$23.0 million; the trailing twelve-month figure through Sep 2022 stood at $15.0 million (changed 0.0% YoY), and the FY2015 full-year result was $61.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments declined to -$23.0 million in Q2 2021, from $38.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $38.0 million in Q1 2021 to a low of -$23.0 million in Q2 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2021 -23.00 Mn
Jun 30, 2021 -23.00 Mn
Mar 31, 2021 38.00 Mn
Mar 31, 2021 38.00 Mn
Sep 30, 2011 1.00 Mn
Sep 30, 2011 1.00 Mn
Dec 31, 2010 3.00 Mn
Dec 31, 2010 3.00 Mn
Dec 31, 2009 37.00 Mn
Dec 31, 2009 37.00 Mn
Sep 30, 2009 4.00 Mn
Sep 30, 2009 4.00 Mn
Mar 31, 2009 50.00 Mn
Mar 31, 2009 50.00 Mn